Therapeutic effects of garlic in cardiovascular atherosclerotic disease

Publication date: October 2019Source: Chinese Journal of Natural Medicines, Volume 17, Issue 10Author(s): Igor A. Sobenin, Veronika A. Myasoedova, Maria I. Iltchuk, Dong-Wei ZHANG, Alexander N. OrekhovABSTRACTGarlic (Allium sativum) is a widely known medicinal plant, potential of which remains to be fully evaluated. Its wide-range beneficial effects appear to be relevant for treatment and prevention of atherosclerosis and related diseases. It is generally believed that garlic-based preparations are able to improve lipid profile in humans, inhibit cholesterol biosynthesis, suppress low density lipoprotein oxidation, modulate blood pressure, suppress platelet aggregation, lower plasma fibrinogen level and increase fibrinolytic activity, thus providing clinically relevant cardioprotective and anti-atherosclerotic effects. It is important to assess the level of evidence available for different protective effects of garlic and to understand the underlying mechanisms. This information will allow adequate integration of garlic-based preparations to clinical practice. In this review, we discuss the mechanisms of anti-atherosclerotic effects of garlic preparations, focusing on antihyperlipidemic, hypotensive, anti-platelet and direct anti-atherosclerotic activities of the medicinal plant. We also provide an overview of available meta-analyses and a number of clinical trials that assess the beneficial effects of garlic.
Source: Chinese Journal of Natural Medicines - Category: Complementary Medicine Source Type: research